Given the critical role of cancer stem cells in promoting cancer progression, scientists examined the impact of forkhead box transcription factor 1 (FOXO1) inhibition with AS1842856 on basal-like breast cancer and glioblastoma multiforme cell viability.
[FEBS Open Bio]